Validation of the Korean version of the European Organization for Research and Treatment of Cancer brain cancer module (EORTC QLQ-BN20) in patients with brain tumors

Table 4 Correlations between the Korean versions of the QLQ-C30 and QLQ-BN20

	C30-PF	C30-RF	C30-EF	C30-CF	C30-SF	C30-QOL
BN20 - FU	-.475^*	-.455^*	-.634^*	-.486^*	-.534^*	-.548^*
VD	-.319^*	-.340^*	-.367^*	-.447^*	-.282^*	-.348^*
MD	-.642^*	-.617^*	-.499^*	-.553^*	-.532^*	-.507^*
CD	-.379^*	-.396^*	-.388^*	-.511^*	-.410^*	-.378^*

^* Correlation is significant at the 0.01 level (2-tailed).
QLQ-C30 Quality of Life Core Questionnaire, QLQ-BN20 Quality of Life Questionnaire Brain Cancer Module, PF physical functioning, RF role functioning, EF emotional functioning, CF cognitive functioning, SF social functioning, QOL quality of life; FU future uncertainty, VD visual disorder, MD motor dysfunction, CD communication deficit.

ISSN: 1477-7525